Nigel Stapleton, PhD’s Post

Save the date: May 13th! 😎 Join us to learn how to streamline timelines and boost efficiency in biotech transfer and development processes. It's going to be insightful! 💡

Yesterday, Wheeler Bio, Inc.'s Chief Manufacturing Officer Yuk Chun Chiu delivered two great presentations at KENX's Validation University Conference. Here, Yuk gave his insight into utilizing risk-based approaches in the commissioning, qualification, and validation (CQV) of single use systems (SUSs) followed by practical considerations for the implementation of a data infrastructure for advanced analytics. We are very proud to have such a great mind representing Wheeler and sharing his knowledge and experiences with the industry. If you did not get the chance to attend Yuk's ISPE or KENX talks, keep an eye out for more great presentations coming later this year! #Bioprocessing #Biopharma #Pharma #Biotech #Innovation

What is the Wheeler Difference? Wheeler Bio, Inc. is bringing a new paradigm to biomanufacturing through our commitment to an open-source, transparent, and predictable service platform made possible by our strong partnership culture. By collaborating with pioneering technology providers and integrating with discovery CROs, we provide our clients with access to the most advanced and effective biomanufacturing solutions while reducing risk and improving efficiency. Collaboration is at the core of the Wheeler model as we believe the only way to build genuine trust is through open communication, unwavering integrity, and consistent results. Let's discuss! In your experience, what are the key factors in building trust with your partners? Let us know in the comments. Explore the Wheeler difference: https://lnkd.in/gAbvMwu5 #pharma #pharmaindustry #biopharma #biotech

Join the upcoming JMP Discovery Summit Europe to enhance your knowledge and expertise in statistics. This conference provides valuable insights, keynote speakers, and practical workshops from top companies. Connect with other professionals and gain the latest tools and techniques. Don't miss out, save your spot today. #JMPDiscoverySummitEurope #Statistics #DataAnalysis #Networking #ProfessionalDevelopment

Struggling with leaks in fluid handling in your biopharmaceutical manufacturing process? Don’t miss this webinar on December 7. Learn about the latest advancement in single-use film technology and how a leak resistant film can benefit your process. http://ms.spr.ly/6042iPyLY

Single-use assemblies are increasingly used for large volume liquid transfer in bioprocessing. While the benefits of single-use technologies are widely recognised, the risk of leaks during handling, processing, transportation, and storage persists. This webinar addresses the challenges manufacturers face using single-use products, advancements made in single-use film technology and the impact extractables and leachables can have on cell growth. Take a step in the right direction and join us for this webinar by clicking on the link below.

Struggling with leaks in fluid handling in your biopharmaceutical manufacturing process? Don’t miss this webinar on December 7. Learn about the latest advancement in single-use film technology and how a leak resistant film can benefit your process. http://ms.spr.ly/6047iHXFU

Exciting times in biopharma! 💊 Drug developers are now embracing lab automation technologies to streamline the drug development process. From start to finish, these innovative technologies cover virtually every stage, making drug discovery faster and more efficient. ✅ They're not just time-savers; they also enhance contamination control, ensure consistent results, standardise procedures, and bolster data security. ➡️ In the latest article for Gen News, Sergey Vlasenko, PhD, Associate Vice President for Pharma and Biopharma End Markets at Agilent Technologies, shares his views about laboratory automation and its potential to revolutionise the entire spectrum of drug development activities– from discovery to production. 🔗https://lnkd.in/ezhYBhD7 #BiopharmaInnovation #LabAutomation #DrugDevelopment

In this video segment from ARE WE THERE YET? ROADMAP(S) TO HIGHER QUALITY AAV, Andrew Tustian, the senior director of preclinical manufacturing and process development for Regeneron, and Justin Horvath, senior director of external manufacturing and manufacturing sciences for REGENXBIO Inc., share their perspectives and provide additional color on audience members’ responses to the first poll question pinpointing the greatest concerns in terms of quality, yield, and the regulatory paradigm. https://lnkd.in/gBjBcx63

💡 In Benchling's webinar, delve into the challenges of modern biopharma development. The speakers, Areef Jetha and Justin De La Cruz, PhD will guide you through overcoming hurdles in cell line development, upstream and downstream processing, and analytical operations for modern drug modalities. ���� Watch the full webinar here: https://buff.ly/3tdircg #CellCulture #ProcessDevelopment #LaboratoryTechnology #CellLineDevelopment